Zimmer Biomet Holdings, Inc. $ZBH Shares Purchased by IFM Investors Pty Ltd

Key Points

• IFM Investors Pty Ltd increased its stake in Zimmer Biomet Holdings, Inc. by 9.6% during the second quarter, acquiring an additional 3,624 shares, bringing their total holdings to 41,199 shares valued at approximately $3.76 million.
• Several large investors, including Wealth Enhancement Advisory Services LLC and Moody National Bank Trust Division, have also made significant adjustments to their holdings in Zimmer Biomet, indicating a strong interest from institutional investors.
• Zimmer Biomet reported quarterly earnings of $2.07 per share, exceeding analysts' expectations, with a year-over-year revenue growth of 7.0%, and declared a quarterly dividend of $0.24 per share.

IFM Investors Pty Ltd lifted its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 9.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 41,199 shares of the medical equipment provider's stock after acquiring an additional 3,624 shares during the quarter. IFM Investors Pty Ltd's holdings in Zimmer Biomet were worth $3,758,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of ZBH. Garde Capital Inc. bought a new stake in Zimmer Biomet during the 1st quarter valued at approximately $29,000. Menard Financial Group LLC purchased a new stake in Zimmer Biomet during the 4th quarter valued at $30,000. Washington Trust Advisors Inc. bought a new stake in Zimmer Biomet in the first quarter worth about $30,000. Columbia River Financial Group LLC purchased a new position in shares of Zimmer Biomet during the first quarter valued at approximately $30,000. Finally, Accent Capital Management LLC purchased a new stake in shares of Zimmer Biomet in the first quarter worth approximately $35,000. Hedge funds and other institutional investors own 88.89% of the company's stock.

Zimmer Biomet Stock Performance

NYSE:ZBH traded up $1.81 during midday trading on Monday, hitting $101.90. The company's stock had a trading volume of 1,531,577 shares, compared to its average volume of 1,336,843. Zimmer Biomet Holdings, Inc. has a fifty-two week low of $89.22 and a fifty-two week high of $114.72. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.87 and a quick ratio of 0.96. The firm has a market cap of $20.19 billion, a P/E ratio of 24.79, a P/E/G ratio of 2.30 and a beta of 0.68. The firm's 50 day moving average is $100.06 and its 200-day moving average is $99.35.

Zimmer Biomet (NYSE:ZBH - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical equipment provider reported $2.07 EPS for the quarter, beating the consensus estimate of $1.98 by $0.09. The business had revenue of $2.08 billion during the quarter, compared to analysts' expectations of $2.06 billion. Zimmer Biomet had a net margin of 10.51% and a return on equity of 12.76%. The business's quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the business posted $2.01 EPS. Zimmer Biomet has set its FY 2025 guidance at 8.100-8.300 EPS. Equities analysts anticipate that Zimmer Biomet Holdings, Inc. will post 8.22 earnings per share for the current fiscal year.

Zimmer Biomet Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.24 per share. The ex-dividend date is Tuesday, September 30th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.9%. Zimmer Biomet's dividend payout ratio (DPR) is presently 23.36%.

Insider Activity at Zimmer Biomet

In related news, SVP Lori Winkler sold 1,500 shares of the business's stock in a transaction on Monday, September 8th. The shares were sold at an average price of $104.15, for a total value of $156,225.00. Following the completion of the transaction, the senior vice president directly owned 6,833 shares in the company, valued at $711,656.95. The trade was a 18.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts recently commented on ZBH shares. Redburn Partners set a $130.00 price target on shares of Zimmer Biomet in a research note on Thursday. Stifel Nicolaus increased their price objective on Zimmer Biomet from $115.00 to $118.00 and gave the stock a "buy" rating in a research note on Friday. Rothschild Redb upgraded Zimmer Biomet to a "strong-buy" rating in a research note on Thursday. Rothschild & Co Redburn initiated coverage on shares of Zimmer Biomet in a report on Thursday. They set a "buy" rating and a $130.00 target price on the stock. Finally, Raymond James Financial boosted their price objective on shares of Zimmer Biomet from $104.00 to $113.00 and gave the stock an "outperform" rating in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $113.16.

Zimmer Biomet Profile

Zimmer Biomet Holdings, Inc, together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.